- 专利标题： PYRROLOPYRIMIDINE COMPOUND AND USE THEREOF
-
申请号： EP20817895.4申请日： 2020-06-05
-
公开(公告)号： EP3981769A1公开(公告)日： 2022-04-13
- 发明人: QIAN, Wenyuan , WEI, Changqing , HU, Guoping , LI, Jian , CHEN, Shuhui
- 申请人： GUANGZHOU JOYO PHARMATECH CO., LTD , Medshine Discovery Inc.
- 申请人地址： CN Guangzhou, Guangdong, 510730 Room 526, Building D, Seat 095, We Zhongchuang Space, No. 39, Ruihe Road, Guangzhou Hi-tech Industrial Development Zone and Science City; CN Nanjing, Jiangsu 210032 Room 218, No. 9 Gaoxin Road Jiangbei New District
- 代理机构： Secerna LLP
- 优先权： CN201910487056 20190605
- 国际公布： WO2020244614 20201210
- 主分类号： C07D487/04
- IPC分类号： C07D487/04 ; C07D519/00 ; A61P29/00 ; A61K31/519
摘要：
The present invention relates to a pyrrolopyrimidine compound used as a JAK inhibitor, and the use thereof in the preparation of a drug for treating a JAK1- and/or JAK2-associated disease, and in specifically relates to a compound represented by formula (I), an isomer thereof or a pharmaceutically acceptable salt thereof.
信息查询
